Names | |
---|---|
Preferred IUPAC name 2-imidazopyridine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.013.589 |
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C14H12N2O2S |
Molar mass | 272.32 g/mol |
Density | 1.31 g/cm |
Pharmacology | |
ATC code | A02BX10 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Zolimidine (zoliridine, brand name Solimidin) is a gastroprotective drug previously used for peptic ulcer and gastroesophageal reflux disease.
See also
References
- Parisio, C; Clementi, F (November 1976). "Surface Alterations Induced by Stress in Gastric Mucosa: Protective Effect of Zolimidine. A Transmission and Scanning Electron Microscope Investigation". Laboratory Investigation. 35 (5): 484–95. PMID 136548.
- Belohlavek, D; Malfertheiner, P (1979). "The Effect of Zolimidine, Imidazopyridine-derivate, on the Duodenal Ulcer Healing". Scandinavian Journal of Gastroenterology. Supplement. 54: 44. PMID 161649.
- Materia, A; Basso, N; Bagarani, M; Basoli, A; Speranza, V (30 April 1981). "Treatment of Alkaline Reflux Gastritis with Zolimidine. Controlled Study". La Clinica Terapeutica. 97 (2): 183–91. PMID 6453678.
Drugs for peptic ulcer and GERD/GORD (A02B) | |
---|---|
H2 antagonists ("-tidine") | |
Prostaglandins (E)/ analogues ("-prost-") | |
Proton-pump inhibitors ("-prazole") | |
Potassium-competitive acid blockers ("-prazan") | |
Others | |
Combinations | |
|
This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |